Infliximab Inflammation
Mostrando 1-5 de 5 artigos, teses e dissertações.
-
1. Effects of anti-TNF-α in experimental diversion colitis
Abstract Purpose: To evaluate the effects of infliximab on the inflammation of the colonic mucosa devoid from fecal stream. Methods: Twenty-four rats were submitted to a Hartmann's procedure. They remained for 12 weeks with the fecal derivation to development of diversion colitis on excluded colorectal stump. After this period, they were divided into 3 gro
Acta Cir. Bras.. Publicado em: 13/12/2019
-
2. Segmental vitiligo after infliximab use for rheumatoid arthritis - A case report
The tumor necrosis factor alpha is a cytokine related to immune and inflammatory processes by acting on different parts of the body. It is secreted by several cell types including macrophages, lymphocytes, monocytes, neutrophils, dendritic cells, among others. Infliximab is a chimeric monoclonal antibody that specifically binds to soluble and transmembrane t
An. Bras. Dermatol.. Publicado em: 2014-01
-
3. Efeito do anticorpo anti-TNF-α, infliximabe, sobre a mucosite intestinal experimental induzida por Irinotecano / Effect of antiboby anti-tnf-α, infliximab, in irinotecan-induced intestinal mucositis in mice
IntroduÃÃo: A mucosite intestinal (MI) Ã um efeito colateral comum e limitante da quimioterapia com irinotecano. Estudos sugerem a participaÃÃo de citocinas, como TNF-α, IL-1β e IL-18 na fisiopatologia da MI, alÃm de demonstrar que inibidores nÃo seletivos de citocinas, como pentoxifilina, atenuam a MI por irinotecano. O papel das citocinas
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 15/07/2012
-
4. Efeito antiinflamatÃrio e antirreabsortivo Ãsseo do infliximabe na periodontite induzida em ratos Wistar. / Anti-inflamatory and anti resorptive bone effect of infliximab in the peridontitis induced in Wistar rats.
A periodontite à uma doenÃa inflamatÃria crÃnica caracterizada pela destruiÃÃo em vÃrios nÃveis do osso alveolar, fibras colÃgenas e do cemento, à considerada importante causa de perda dentÃria em adultos. O infliximabe (RemicadeÂ) à um medicamento composto de anticorpo quimÃrico monoclonal do fator de necrose tumoral-alfa (TNF-α), sendo u
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 17/01/2012
-
5. Could toll‐like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue
In the last decade the development of a number of biological therapies has revolutionised the treatment of rheumatic diseases. The first and most widely used of these approaches, tumour necrosis factor (TNF) blockade (infliximab, entanercept, adalimumab), has now been administered to over a million patients. However, the success of these biological therapies
BMJ Group.